BREAKING NEWS & UPDATES

RBI’s New MSME Lending Guidelines Could Block Loans for Millions of Small Businesses in 2026

The Reserve Bank of India’s revised lending norms for micro, small, and medium enterprises are set to tighten credit access for millions of small business owners across India. Banks will now require stricter collateral and credit score thresholds, potentially leaving 40% of existing MSME borrowers ineligible for fresh loans. New Delhi, April 2026 — India’s 63 million small businesses are...

Bengal BJP Chief Escalates Attack on Trinamool Government Amid 2026 Assembly Positioning

West Bengal’s Leader of Opposition has launched a fresh offensive against the ruling Trinamool Congress, signaling intensified BJP aggression ahead of crucial political battles. The Kolkata press conference marks a strategic pivot as BJP attempts to consolidate its position in a state where it remains the primary challenger. New Delhi, April 2026 — The political temperature in West Bengal has...

Tamil Nadu Assembly Elections 2026: DMK Launches Aggressive Campaign Blitz in Western Districts

Tamil Nadu’s ruling DMK has kicked off an intensive election campaign in the industrially crucial western belt, with Chief Minister M.K. Stalin personally leading rallies in key constituencies. The 2026 Assembly polls are shaping up as a high-stakes battle for the Dravidian party seeking to retain power amid rising AIADMK and BJP pressure. Coimbatore, April 2026 — Chief Minister M.K....

Weight Loss Drug Semaglutide Floods Indian Market: Is Unregulated GLP-1 Medicine Safe for You?

Semaglutide, the viral weight-loss drug known globally as Ozempic and Wegovy, is now widely available across India at a fraction of international prices—but with minimal medical oversight. Health experts warn that unchecked self-medication could trigger serious side effects, while demand continues to explode among urban Indians chasing quick weight loss. New Delhi, April 2026 — Indian pharmacies and online platforms...

DAILY FEED

FEATURED STORIES

Sign up for the Spotlight Newsletter: